By Carl O’Donnell and Michael Erman NEW YORK (Reuters) – The COVID-19 vaccine for children aged 5 to 11 from Pfizer Inc and BioNTech SE has been authorized by the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention.
By Carl O’Donnell and Michael Erman NEW YORK (Reuters) – The COVID-19 vaccine for children aged 5 to 11 from Pfizer Inc and BioNTech SE has been authorized by the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention.



